TGF-Beta Signaling in Bone with Chronic Kidney Disease
AbstractTransforming growth factor (TGF)-β signaling is not only important in skeletal development, but also essential in bone remodeling in adult bone. The bone remodeling process involves integrated cell activities induced by multiple stimuli to balance bone resorption and bone formation. TGF-β plays a role in bone remodeling by coordinating cell activities to maintain bone homeostasis. However, mineral metabolism disturbance in chronic kidney disease (CKD) results in abnormal bone remodeling, which leads to ectopic calcification in CKD. High circulating levels of humoral factors such as parathyroid hormone, fibroblast growth factor 23, and Wnt inhibitors modulate bone remodeling in CKD. Several reports have revealed that TGF-β is involved in the production and functions of these factors in bone. TGF-β may act as a factor that mediates abnormal bone remodeling in CKD. View Full-Text
Share & Cite This Article
Iwasaki, Y.; Yamato, H.; Fukagawa, M. TGF-Beta Signaling in Bone with Chronic Kidney Disease. Int. J. Mol. Sci. 2018, 19, 2352.
Iwasaki Y, Yamato H, Fukagawa M. TGF-Beta Signaling in Bone with Chronic Kidney Disease. International Journal of Molecular Sciences. 2018; 19(8):2352.Chicago/Turabian Style
Iwasaki, Yoshiko; Yamato, Hideyuki; Fukagawa, Masafumi. 2018. "TGF-Beta Signaling in Bone with Chronic Kidney Disease." Int. J. Mol. Sci. 19, no. 8: 2352.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.